These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 221426)

  • 21. Hepatitis-associated antigen in liver diseases.
    Chang CK; Shih PL; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):146-59. PubMed ID: 4341745
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B antigen and auto-antibodies in chronic liver diseases in Hong Kong.
    Lee AK
    Aust N Z J Med; 1975 Jun; 5(3):235-9. PubMed ID: 169780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects.
    Worrall S; De Jersey J; Shanley BC; Wilce PA
    Alcohol Alcohol; 1990; 25(5):509-17. PubMed ID: 1708257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
    Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
    Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
    Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
    Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum gamma-globulins and hepatitis-associated antigen in blood donors, chronic liver disease and primary hepatoma.
    Hirayama C; Tominaga K; Irisa T; Nakamura M
    Digestion; 1972; 7(5):257-65. PubMed ID: 4135905
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms of abnormalities in host defences against bacterial infection in liver disease.
    Rajkovic IA; Williams R
    Clin Sci (Lond); 1985 Mar; 68(3):247-53. PubMed ID: 2982530
    [No Abstract]   [Full Text] [Related]  

  • 29. The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers.
    Bonino F; Pinna G; Recchia S; Rizzetto M
    Ric Clin Lab; 1976; 6(3):251-7. PubMed ID: 1025647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum level of tissue polypeptide antigen and its mechanism of elevation in patients with benign liver diseases and hepatocellular carcinoma].
    Arashiyama Y; Watanabe F; Miyazaki H; Ogoshi H; Oizumi H
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):927. PubMed ID: 6086987
    [No Abstract]   [Full Text] [Related]  

  • 31. IgM responses to hepatitis-A virus and hepatitis-B core antigen in acute and chronic liver disease in Malawi; possible role of non-A, non-B, hepatitis.
    Supran EM; Molyneux ME; Banatvala JE
    Trans R Soc Trop Med Hyg; 1980; 74(3):389-92. PubMed ID: 6254219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing frequency, with time, of hepatitis B surface antigen positive liver biopsy in hepatitis, cirrhosis, and hepatocellular carcinoma.
    Senba M; Nakamura T; Toda T; Matsumura H
    Lancet; 1988 Mar; 1(8585):588-9. PubMed ID: 2894519
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B virus infection and chronic liver disease in Taiwan.
    Chen DS; Sung JL
    Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):423-30. PubMed ID: 214987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Disease: Advances in Diagnosis, Treatment and Clinical Practice. AASLD Liver Meeting, Boston, November 7-11, 2014].
    Pár A
    Orv Hetil; 2015 May; 156(21):869-72. PubMed ID: 26038995
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autoimmune reaction of the 'Chişiu type" in chronic liver diseases].
    Costică II; Dumitriu M; Benea F
    Med Interna (Bucur); 1973 Jun; 25(6):693-7. PubMed ID: 4793940
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of hepatitis associated antigen in chronic liver disease in Southern Italy.
    Del Vecchio-Blanco C; Carrella M; Coltorti M
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):138-42. PubMed ID: 4356375
    [No Abstract]   [Full Text] [Related]  

  • 38. Australia antigen in acute and chronic liver disease.
    Wright R; McCollum RW; Klatskin G
    Lancet; 1969 Jul; 2(7612):117-21. PubMed ID: 4183241
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection and characterization of antibody to liver cell membrane in sera from patients with chronic active liver diseases.
    Tsuji T; Araki K; Naito K; Inoue J; Nacashima H
    Acta Med Okayama; 1979 Feb; 33(1):61-6. PubMed ID: 220848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].
    Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M
    Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.